BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Consumer Health

Chula Researchers Develop Rapid MTB Strip Test for Tuberculosis

Tuberculosis is one of the most contagious diseases that continues to challenge the public health system today. Although the World Health Organizatio...

May 03, 2023 | News

Health Canal Survey: Why Older Adults are Hesitant to Receive the Bivalent Booster Shot

The CDC has recommended the bivalent mRNA COVID-19 vaccines since September 2022, yet only 42.4 percent of older adults have received the updated vacc...

May 02, 2023 | News

HOYA elevates children's myopia and light protection with MiYOSMART Sun lenses.

Origins of MiYOSMART lenses Developed by HOYA Vision Care in cooperation with The Hong Kong Polytechnic University, MiYOSMART is a line of innovative opht...

April 30, 2023 | News

Healint announces collaboration with Saitama Medical University Hospital in Japan to verify AI diagnosis of migraine

Although there are currently 30 million chronic headache patients in Japan, the diagnosis and treatment rate of migraine among non-headache specialist...

April 28, 2023 | News

Fosun Pharma Develops Innovative Artemisinin-based Antimalarials for Malaria-free World via Belt and Road

This year 2023 also marks the 10th anniversary of the Belt and Road Initiative. Medicine knows no borders. Artemisinin and its derivatives have moved ...

April 27, 2023 | News

500 women join Australia's landmark maternity medical device study

The study was led by Principal Investigators Professor Michael Nicholls, Professor Andrew Bisits and Michelle de Vroom at two Aust...

April 20, 2023 | News

Scientists from Singapore and Sweden achieve promising results towards restoring vision in blindness caused by cellular degeneration in the eye

A preclinical study using stem cells to produce progenitor photoreceptor cells—light-detecting cells found in the eye—and then transplanting th...

April 17, 2023 | News

Pharming ships Joenja® (leniolisib) to U.S. patients

Under the terms of Pharming's 2019 exclusive license agreement with Novartis for leniolisib, the corresponding first commercial sale of Joenja® trigger...

April 11, 2023 | News

Helfgott Institute Gets Funding to Test Mind-Body Practices for Benzodiazepine Reduction

This one-time opportunity is made possible by the US Deprescribing Network, funded by the National Institute on Aging, in support of complementary and...

April 10, 2023 | News

BGI Global's Colorectal Cancer Survey uncovers gaps in awareness and concerns over affordability

This inaugural report seeks to better understand the global state of CRC awareness, as well as attitudes and actions towards CRC screening for average risk...

April 07, 2023 | News

Tuberculosis patients see dramatic cut in treatment duration, treatment effectiveness remains

The TRUNCATE-TB trial recruited 675 people who were diagnosed with pulmonary TB and randomly allocated them to receive the standard treatment for six...

April 06, 2023 | Analysis

Roche Diagnostics India Unveils #BeYourOwnShero Campaign to Educate Women About Cervical Cancer Prevention

Cervical Cancer is India’s second most common cancer, affecting more than 1.23 lakh women each year. Around 77,000 Indian women die of the disease. D...

April 05, 2023 | News

Metabolon Launches Targeted Panels to Study Microbiome and Gut Metabolome in Health and Disease

Metabolon, Inc., the global leader in providing metabolomics solutions that advance a wide variety of research, diagnostic, therapeutic development, and pr...

April 05, 2023 | News

Standigm, Institut Pasteur Korea identify drug candidates for drug-resistant TB with grant

Standigm, a company using artificial intelligence (AI) technology for drug discovery and development, and Korean non profit research institute Instit...

April 05, 2023 | News

Stay Connected